BetaPro Equal Weight Can...【HRED】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
ETF
カナダ
TSX
BetaPro Equal Weight Canadian REIT 2x Daily Bear ETF (HRED) 銘柄情報

BetaPro Equal Weight Canadian REIT 2x Daily Bear ETF (HRED)

14.69

-0.33

(-2.20%)

終了 1月2日 6:12AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

14.69

買値

14.59

売値

14.76

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

15.02

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

-

配当利回り

-

PER

0.00

1 株当たり利益 (EPS)

-

歳入

1.24M

純利益

1.01M

セクター

Finance Services

業界

Finance Services

本社

, Can

設立

-

BetaPro Equal Weight Canadian REIT 2x Daily Bear ETF is listed in the Finance Services sector of the トロント証券取引所 with ticker HRED. The last closing price for BetaPro Equal Weight Can... was $15.02. Over the last year, BetaPro Equal Weight Can... shares have traded in a share price range of $ 0.00 to $ 0.00.

BetaPro Equal Weight Can... currently has 0 shares in issue.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BDMDBaird Medical Investment Holdings Ltd	US$ 7.6699 (630.47%)	89.74M
APMAptorum Group Ltd	US$ 2.799 (106.57%)	116.74M
COEPCoeptis Therapeutics Holdings Inc	US$ 5.44 (75.48%)	5.08M
VRMEVerifyMe Inc	US$ 1.332 (68.63%)	94.04M
VEEETwin Vee PowerCats Company	US$ 0.55 (53.59%)	5.62M
WATTEnergous Corporation	US$ 1.00 (-62.26%)	29.33M
SGMOSangamo Therapeutics Inc	US$ 1.02 (-56.41%)	44.56M
INTZIntrusion Inc	US$ 3.07 (-45.95%)	15.07M
KZIAKazia Therapeutics Ltd	US$ 1.78 (-42.58%)	708.99k
TOIIWOncology Institute Inc	US$ 0.0052 (-42.22%)	366.02k
SVMHSRIVARU Holding Ltd	US$ 0.0423 (26.65%)	794.74M
XTIAXTI Aerospace Inc	US$ 0.0422 (6.84%)	446.31M
EYENEyenovia Inc	US$ 0.1474 (30.10%)	412.83M
CRKNCrown Electrokinetics Corporation	US$ 0.146899 (5.91%)	402.05M
ONCOOnconetix Inc	US$ 0.6479 (48.26%)	270.47M

jimr1717

jimr1717 5分前

Latest ATMH DD>> 🏆️

Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobil

StonkMaster

StonkMaster 6分前

So it took nearly a year from the first CHM meeting to approve a drug that is already approved elsewhere worldwide? That's not super encouraging.

RobotDroid

RobotDroid 6分前

Inept mute nonmanagement is silent because they only have bad news to report. This clown show continues into 2025 and will only get worse as long as Linda the Grifter Worthless is in charge.

baltimorebullet

baltimorebullet 7分前

Do we have insider information?

LTListener

LTListener 7分前

You would think listing correct management and BOD would be important!

And all 3 platforms have way outdated information!

It is illogical to cry about lack of funding and otc liquidity when you present the company like a 6th grade science project..

Yet ex

dbergh

The Trump Sequel: What to Expect on PBMs, 340B, Drug Pricing, and RFK Jr November 12, 2024

AJMC: The Federal Trade Commission has been very active in looking into practices of PBMs, even pursuing litigation. As you noted, litigation between administrations does not always continue.

Guido2

I side with Patswil.

weedtrader420

weedtrader420 9分前

🖕🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🖕

weedtrader420

weedtrader420 9分前

northam43

northam43 10分前

Report 9.1 SPX Cycles 12 Month Low/High Projection Range

https://investorshub.advfn.com/uimage/uploads/2025/1/1/qjf[t9.1_12_Month_Range.PNG

dedugan

dedugan 11分前

I would like everything you said to be true.
But you said "We have had a number of sources close to Moez Kassam write to inform us that Moez/Anson have recently received a sealed indictment.
According to these sources they have been found guilty."
An indictment is not a guilty

capgain

capgain 11分前

Fingerprint File (Live / Remastered 2009)

https://www.youtube.com/watch?v=Hcr-wMyFY2s

Lykiri

Lykiri 11分前

It wasn’t an easy task, but I concluded that there were probably 3 or 4.

Here is medicine number 4, approved by MHRA on 31 December 2024.

Tarlatamab approved to treat adult patients with small cell lung cancer.

The Medicines and Healthcare products Regula

northam43

northam43 11分前

Report 9.1 SPX Cycles 12 Month Low/High Projection Range

https://investorshub.advfn.com/uimage/uploads/2025/1/1/qjf[t9.1_12_Month_Range.PNG

NoMoDo

NoMoDo 11分前

Don't tell me scores, because I am delayed a bit. But yes, dominating.

scortech

scortech 12分前

Here's to believing this is really the goal in 2025
https://investorshub.advfn.com/uimage/uploads/2025/1/1/chiwoART.png

Tr8dervic

Tr8dervic 12分前

Mega Millions numbers for 12/31/24 are:

13 22 27 29 35 Mega Ball 01

Estimated Jackpot: $20 Million Cash Option: $9.0 Million

Next Estimated Jackpot
$42 Million
Cash Option: $18.8 Million
Next Drawing:
Friday, 1/3/24 @ 11 p.m. E

Dcab

I am disappointed but the original estimate was 6 to 8 weeks which was stated on Nov 7th. The 8 week estimate falls on this week but the holidays probably added more time. Hopefully news by next week. Jmho

GolfnutBoston

GolfnutBoston 12分前

Hi,
Thank you for sharing but not necessarily why I mentioned year in review update. I meant it with my sometimes dry humor that most companies issue a year end update recapping achievements, milestones of the past year and expressing gratitude to shareholders for support etc. and of course n

BDEZ

Agree MG, hot mess right now....

TenKay

TenKay 14分前

Why do people think they would buy out HMBL? They will have voting control and at least 40% of the common with the merger with YBYRA…

They don’t need to “buy out” anything.

longtermbeliever

longtermbeliever 14分前

with this news plus the full data of ole to present at JPM WOW i think we going to have some fireworks.JUST HOLD ON TIGHT LOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOONGS

dinogreeves

dinogreeves 14分前

Homebrew, what makes you think this a garbage ticker? I have no quarrel with the rest.

BetaPro Equal Weight Can...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約